Nov 04, 2019
Press Releases
ViaCyte to Present at ISSCR International Symposium: Stem Cell Biology to New Therapies
SAN DIEGO, November 4, 2019 – ViaCyte, Inc., a privately-held clinical-stage regenerative medicine company, announced an upcoming presentation at From Stem Cell Biology to New Therapies, an ISSCR International Symposium being held in Toronto. ViaCyte is developing novel stem cell-derived islet replacement therapies for insulin-requiring diabetes. For type 1 diabetes, ViaCyte has two product candidates, […]